查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1747494

第三代定序市场：依技术类型、按组件、按应用、按最终用户、按地区

Third Generation Sequencing Market, By Type of Technology, By Component, By Application:, By End-User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2025年第三代定序市场规模为8.814亿美元，到2032年将达到33.665亿美元，2025年至2032年的复合年增长率为21.1%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 8.814亿美元
效能数据 2020-2024 预测期 2025-2032
预测期：2025-2032年复合年增长率： 21.10% 2032年价值预测 33.665亿美元

第三代定序（也称为长读长定序）是DNA定序方法的一种分类。第三代定序透过在单分子层次上读取核苷酸序列来运作，可以产生比现有方法更长的读长。它能够产生比第二代定序（也称为次世代定序）更长的读长。此外，第三代定序已成为cDNA定序的「黄金标准」技术。

市场动态：

慢性病和感染疾病病率的上升、临床诊断应用的增加、基因组学应用的扩大、对药物发现和营销的日益关注以及传统技术的效率的提高是预计推动全球第三代定序市场增长的一些关键因素。

例如，随着慢性病负担的加重，基于第三代定序技术的仪器的使用和需求也在快速成长。第三代定序技术可用于研究慢性病的基因表现，有助于理解慢性病的分子机制。根据世界卫生组织（WHO）2023年9月的报告，非传染性疾病（NCD）每年导致全球4,100万人死亡，占全球死亡总数的74%。其中，心血管疾病是导致NCD死亡的主要原因，每年约有1,790万人死亡，其次是癌症（930万人）、慢性呼吸道疾病（410万人）和糖尿病（200万人）。

此外，根据美国疾病管制与预防中心 (CDC) 的数据，心臟病、癌症和糖尿病等慢性疾病是美国死亡和残疾的主要原因。

本研究的主要特点

  • 本报告对全球第三代定序市场进行了详细分析，并以 2024 年为基准年，给出了预测期 2025-2032 的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 该报告涵盖了全球第三代定序市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、关键亮点、财务表现和策略。
  • 人们相信，本报告的见解可以帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球第三代定序市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球第三代定序市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 精准医疗需求不断成长
    • 高成本和技术挑战
    • 扩大TGS平台的采用
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章 第三代定序市场（依技术划分），2025-2028

  • 单分子即时（SMRT）定序
  • 奈米孔定序
  • 合成长读定序

5. 第三代定序市场（依组件划分），2020 年至 2028 年

  • 产品
  • 装置
  • 试剂和耗材
  • 服务

第六章 第三代定序市场（依应用）2025-2028

  • 基因组序列分析
  • 表观遗传学
  • 转录组学
  • 总体基因体学
  • 其他的

7. 第三代定序市场（依最终使用者划分），2025 年至 2028 年

  • 生物製药公司
  • 医院和诊所
  • 合约研究组织（CRO）
  • 其他的

第 8 章第三代定序市场、区域、2020-2032 年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第九章 竞争态势

  • PacBio
  • Oxford Nanopore Technologies, Ltd.
  • BGI Genomics Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Agilent Technologies, Inc.
  • GenapSys Inc.
  • Loop Genomics
  • Nabsys, Inc.
  • Genia Technologies, Inc.
  • Stratos Genomics, Inc.
  • GATC Biotech AG
  • Phase Genomics, Inc.

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5721

Third Generation Sequencing Market is estimated to be valued at USD 881.4 Mn in 2025 and is expected to reach USD 3,366.5 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 21.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 881.4 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 21.10% 2032 Value Projection: USD 3,366.5 Mn

Third-generation sequencing (also known as long-read sequencing) is a class of DNA sequencing methods. Third-generation sequencing works by reading nucleotide sequences at a single molecule level, which is capable of producing substantially much longer reads than the current methods. It has the ability to generate longer reads than second-generation sequencing, also known as next-generation sequencing. Moreover, third-generation sequencing has emerged as the 'gold-standard' technology for cDNA sequencing.

Market Dynamics:

Rising prevalence of chronic and infectious diseases, increasing applications in clinical diagnosis, growing applications of genomics, rise in focus on drug discovery and development, and growing efficiency compared to traditional technologies are major factors expected to propel growth of the global third generation sequencing market.

For instance, with the rise in burden of chronic disease, the usage or demand for third-generation sequencing technology-based devices is also increasing with a rapid pace. TGS technologies can be utilized in studying gene expression of chronic diseases as it help in understanding their molecular mechanisms. According to the World Health Organization (WHO), September 2023 report, non-communicable diseases (NCDs) kill 41 million individuals each year, equivalent to 74% of all deaths worldwide. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million).

Moreover, according to the Centers for Disease Control and Prevention (CDC), chronic diseases such as heart disease, cancer, and diabetes are the leading causes of death and disability in the U.S.

Key features of the study:

  • This report provides in-depth analysis of the global third generation sequencing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global third generation sequencing market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include PacBio , Oxford Nanopore Technologies, Ltd., BGI Genomics Co., Ltd., F. Hoffmann-La Roche AG, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Agilent Technologies, Inc., GenapSys Inc., Loop Genomics, Nabsys, Inc., Genia Technologies, Inc., Stratos Genomics, Inc., GATC Biotech AG, and Phase Genomics, Inc., among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global third generation sequencing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global third generation sequencing market.

Detailed Segmentation:

  • By Technology:
    • Single-Molecule Real-Time (SMRT) Sequencing
    • Nanopore Sequencing
    • Synthetic long-read sequencing
  • By Component:
    • Products
    • Instruments
    • Reagents and consumables
    • Services
  • By Application:
    • Genome Sequencing
    • Epigenetics
    • Transcriptomics
    • Metagenomics
    • Others
  • By End-user:
    • Biopharmaceutical companies
    • Hospitals and clinics
    • Contract research organizations (CROs)
    • Others (Academic and research institutes)
  • By Geography:
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East and Africa
  • Company Profiles:
    • PacBio
    • Oxford Nanopore Technologies, Ltd.
    • BGI Genomics Co., Ltd.
    • F.Hoffmann-La Roche AG
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • QIAGEN N.V.
    • Agilent Technologies, Inc.
    • GenapSys Inc.
    • Loop Genomics
    • Nabsys, Inc.
    • Genia Technologies, Inc.
    • Stratos Genomics, Inc.
    • GATC Biotech AG
    • Phase Genomics, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Third Generation Sequencing, By Type of Technology
    • Market Third Generation Sequencing, By Component
    • Market Third Generation Sequencing, By Application
    • Market Third Generation Sequencing, By End User
    • Market Third Generation Sequencing, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Growing Demand for Precision Medicine
    • High Cost & Technical Challenges
    • Increasing Adoption of TGS Platforms
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Third Generation Sequencing Market, By Technology, 2025-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020-2032
    • Segment Trends
  • Single-molecule real-time (SMRT) sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Nanopore Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Synthetic long-read sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

5. Third Generation Sequencing Market, By Component, 2020-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2020-2032
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Instruments
  • Reagents and consumables
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Third Generation Sequencing Market, By Application, 2025-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Genome Sequencing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Epigenetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Metagenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Third Generation Sequencing Market, By End User, 2025-2028, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Biopharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Contract research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Third Generation Sequencing Market, By Geography, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Mn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • PacBio
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Oxford Nanopore Technologies, Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BGI Genomics Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GenapSys Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Loop Genomics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nabsys, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Genia Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Stratos Genomics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GATC Biotech AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phase Genomics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performanc
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us